GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Paragon Care Ltd (FRA:PXS) » Definitions » Cash Receipts from Operating Activities

Paragon Care (FRA:PXS) Cash Receipts from Operating Activities : €3,029 Mil (TTM As of Dec. 2024)


View and export this data going back to . Start your Free Trial

What is Paragon Care Cash Receipts from Operating Activities?

Paragon Care's Cash Receipts from Operating Activities for the six months ended in Dec. 2024 was €1,174 Mil.

Paragon Care's Cash Receipts from Operating Activities for the trailing twelve months (TTM) ended in Dec. 2024 was €3,029 Mil.


Paragon Care Cash Receipts from Operating Activities Historical Data

The historical data trend for Paragon Care's Cash Receipts from Operating Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Paragon Care Cash Receipts from Operating Activities Chart

Paragon Care Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Cash Receipts from Operating Activities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 163.12 170.64 192.12 207.01 1,962.85

Paragon Care Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Cash Receipts from Operating Activities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 104.81 105.09 106.82 1,855.49 1,173.93

Paragon Care Cash Receipts from Operating Activities Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Cash Receipts from Operating Activities represents cash received from operating activitiies in direct method.

GuruFocus lists following items in "Cash Receipts from Operating Activities" section for non-financial companies:
Receipts from Customers
Receipts from Government Grants
Other Cash Receipts from Operating Activities

Cash Receipts from Operating Activities for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €3,029 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Paragon Care Cash Receipts from Operating Activities Related Terms

Thank you for viewing the detailed overview of Paragon Care's Cash Receipts from Operating Activities provided by GuruFocus.com. Please click on the following links to see related term pages.


Paragon Care Business Description

Industry
Traded in Other Exchanges
Address
77-97 Ricketts Road, Mount Waverley, Melbourne, VIC, AUS, 3149
Paragon Care Ltd is a medical device company. The company provides medical equipment, devices, and consumables medical products to the healthcare market. The company provides solutions to various healthcare markets, aged care, and veterinary markets. The group is organized into two operating segments: ParagonCare and CH2 Holdings and the majority of its revenues are generated from the CH2 Holdings segment engaged in the distribution of pharmaceuticals, medical consumables, nutritional, and over-the-counter products to the healthcare market.